跳至主要内容
临床试验/NCT05492383
NCT05492383已完成不适用

SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)

Opsens, Inc.12 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2022年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Opsens, Inc.
入组人数
119
试验地点
12
主要终点
Percentage of patients with effective rapid pacing run

研究概览

简要总结

The purpose of the clinical investigation is to determine efficacy and safety of using the rapid pacing of SavvyWire™ during TAVI procedures.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

Investigation participant number only

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is at least 18 years old
  • Subject has a severe symptomatic AS undergoing a TAVI procedure
  • Subject with a THV for which rapid pacing is considered necessary during valve implantation
  • Subject agrees to participate in the study and is able to sign the informed consent form

排除标准

  • Failure to provide signed informed consent
  • Extremely horizontal aorta (aortic root angle ≥70°)
  • Extreme tortuosity at the level of the iliofemoral arteries, thoracic or abdominal aorta
  • Inability to receive full anticoagulation during the TAVI procedure
  • Prohibitive surgical risk precluding (according to the Heart Team) conversion to open heart surgery in case of a life-threatening complication.

结局指标

主要结局

Percentage of patients with effective rapid pacing run

时间窗: during surgery

Effective rapid pacing will be defined as an adequate ventricular pacing capture by the SavvyWireTM leading to a reduction of systolic aortic pressure value \<60 mmHg.

次要结局

  • Percentage of patients with hemodynamic assessment without additional manipulation (pressure efficacy)(during surgery)
  • Percentage of patient with valve advancement to intended position (mechanical efficacy)(during surgery)
  • Presence of major complications (safety)(during surgery)

研究者

发起方
Opsens, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验